heart disease

Erectile dysfunction linked to cardio risk

Graham Stocks — Wed, 09 Jun 2010 23:23:32 -0700

Data from two recent studies suggest that erectile dysfunction (ED) is a common manifestation of cardiovascular risk.

Steps towards a healthy heart

Graham Stocks — Wed, 09 Jun 2010 21:16:35 -0700

Good cardio health is becoming more and more important for people with HIV. Sean Slavin explains why and the steps we can take to improve our prospects.

Cardiovascular Health

Graham Stocks — Wed, 07 Apr 2010 18:53:09 -0700

Cardiovascular disease (CVD) refers to a group of diseases and illnesses of the heart and blood vessels and includes:

coronary arteryOne of the two arteries that supply the heart with oxygenated blood. disease (narrowing of the arteries that supply blood to the heart, which can lead to chest pain [anginatemporary chest pain or a sensation of pressure due to a lack of oxygen supply to the heart. Also called angina pectoris.] or heart attacks)
cerebrovascular disease (strokes and other problems with blood vessels in the brain)

Fosamprenavir linked to heart problems

Graham Stocks — Wed, 03 Mar 2010 21:34:59 -0800

In December, GlaxoSmithKline (GSK) issued a letter alerting clinicians to the potential association between use of their protease inhibitor fosamprenavir (Telzir) and dyslipidemia (abnormal blood fatA fat. levels) and myocardial infarction (heart attackA life-threatening emergency in which the blood supply to the heart is suddenly cut off, causing the heart muscle (myocardium) to die from lack of oxygen.).

Fosamprenavir linked to cardio risk

Wed, 19 Aug 2009 21:38:48 -0700

A French case-control study has reported an association between exposure to fosamprenavir and an increased risk of heart attackA life-threatening emergency in which the blood supply to the heart is suddenly cut off, causing the heart muscle (myocardium) to die from lack of oxygen.. This may be related to the propensity for this drug classA group of anti-HIV drugs with the same target of action. Anti-HIV drug classes include nucleoside analogue reverse transcriptase inhibitors, protease inhibitors and non-nucleoside analogue reverse transcriptase inhibitors, as well as several others. Combining drugs from three or more classes is the basis of Highly Active Antiretroviral Therapy (HAART). to raise blood lipids.

HAART on the heart

Jill Sergeant — Thu, 04 Jun 2009 23:20:40 -0700

Starting Highly Active AntiretroviralA medication or other substance which is active against retroviruses such as HIV. Therapy can improve some of the things that lead to heart problems but not all of them, a recent study has revealed. Arteries which are already thickened or hardened do not improve on treatment. Metabolic complications, including increases in blood levels of lipids, are common in people on treatment and can also contribute to this condition.

Treatment news from CROI

Paul Kidd — Thu, 12 Mar 2009 17:35:40 -0700

John Daye reports on treatments developments from the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in Montréal, Canada.

Webcast – HIV Health and Treatments Update 2008

Paul Kidd — Thu, 04 Dec 2008 23:11:38 -0800

HIV positive? Want to hear the latest about HIV treatments and health? You should, because there have been important developments in HIV treatments over the past year. To catch up with the latest information, watch a webcast of a community treatment update held in Sydney on 25 November.

ASHM 2008: Treatment side effects

David Menadue — Mon, 24 Nov 2008 16:42:29 -0800

Abacavir should be avoided by people who are in the high cardiovascular risk group.

Minimising the risk of cardiovascular disease (updated)

Brent Beadle — Wed, 25 Jun 2008 19:57:22 -0700

This Treataware fact sheet explains the current knowledge about cardiovascular (heart) disease risk in people living with HIV/AIDS, and some strategies for minimising risk.